Jonathan S. Duke-Cohan, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hair Color | 2 | 2020 | 131 | 0.830 |
Why?
|
| Cell Dedifferentiation | 1 | 2022 | 122 | 0.790 |
Why?
|
| Exocytosis | 1 | 2020 | 320 | 0.630 |
Why?
|
| Receptors, Antigen, T-Cell | 5 | 2024 | 2549 | 0.590 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2022 | 1348 | 0.570 |
Why?
|
| Proteoglycans | 1 | 2020 | 803 | 0.560 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 6 | 2024 | 800 | 0.540 |
Why?
|
| GTPase-Activating Proteins | 1 | 2018 | 470 | 0.490 |
Why?
|
| Membrane Proteins | 7 | 2020 | 7851 | 0.470 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 1720 | 0.410 |
Why?
|
| Smallpox Vaccine | 2 | 2009 | 77 | 0.380 |
Why?
|
| Semaphorins | 6 | 2018 | 96 | 0.380 |
Why?
|
| Protein Array Analysis | 3 | 2011 | 399 | 0.380 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 1085 | 0.370 |
Why?
|
| Vaccinia virus | 2 | 2009 | 329 | 0.350 |
Why?
|
| Glycoproteins | 4 | 2018 | 2203 | 0.280 |
Why?
|
| Antigens, Viral | 3 | 2012 | 989 | 0.270 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 2244 | 0.260 |
Why?
|
| Thymus Gland | 4 | 2022 | 1243 | 0.260 |
Why?
|
| Membrane Microdomains | 1 | 2006 | 205 | 0.250 |
Why?
|
| Complementarity Determining Regions | 2 | 2016 | 149 | 0.250 |
Why?
|
| Mice, Knockout | 7 | 2022 | 14392 | 0.230 |
Why?
|
| Mice, Inbred C3H | 2 | 2020 | 914 | 0.220 |
Why?
|
| Histocompatibility Antigens | 3 | 2019 | 467 | 0.210 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2020 | 107 | 0.180 |
Why?
|
| Melanoma-Specific Antigens | 1 | 2019 | 74 | 0.170 |
Why?
|
| Antibodies, Bispecific | 1 | 2022 | 196 | 0.160 |
Why?
|
| Peromyscus | 1 | 2019 | 16 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2021 | 346 | 0.160 |
Why?
|
| Agouti Signaling Protein | 1 | 2019 | 23 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2020 | 223 | 0.160 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2021 | 528 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 4 | 2018 | 1334 | 0.160 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 3 | 2016 | 263 | 0.160 |
Why?
|
| Mice | 15 | 2024 | 81326 | 0.150 |
Why?
|
| Cell Adhesion | 3 | 2018 | 3091 | 0.150 |
Why?
|
| Antibodies, Viral | 2 | 2009 | 3149 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 4 | 2018 | 4404 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2018 | 2871 | 0.150 |
Why?
|
| Cell Movement | 4 | 2018 | 5195 | 0.140 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2018 | 235 | 0.140 |
Why?
|
| Pyroglyphidae | 1 | 2017 | 89 | 0.140 |
Why?
|
| Phosphoproteins | 1 | 2006 | 2444 | 0.140 |
Why?
|
| Membrane Glycoproteins | 4 | 2018 | 3696 | 0.140 |
Why?
|
| HIV Seropositivity | 1 | 2022 | 957 | 0.130 |
Why?
|
| Animals | 21 | 2024 | 168079 | 0.130 |
Why?
|
| Integrins | 2 | 2018 | 835 | 0.130 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2021 | 424 | 0.130 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2019 | 509 | 0.130 |
Why?
|
| Peptides | 3 | 2022 | 4353 | 0.130 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2019 | 822 | 0.130 |
Why?
|
| Cancer Vaccines | 1 | 2023 | 1038 | 0.130 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2017 | 271 | 0.130 |
Why?
|
| Ligands | 5 | 2021 | 3264 | 0.120 |
Why?
|
| Cell Membrane | 2 | 2018 | 3661 | 0.120 |
Why?
|
| Selection, Genetic | 1 | 2019 | 871 | 0.110 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1089 | 0.110 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 11856 | 0.110 |
Why?
|
| Jurkat Cells | 3 | 2020 | 739 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 4574 | 0.110 |
Why?
|
| Protein Binding | 7 | 2020 | 9297 | 0.110 |
Why?
|
| src Homology Domains | 2 | 2020 | 361 | 0.100 |
Why?
|
| COS Cells | 2 | 2020 | 1129 | 0.090 |
Why?
|
| CD40 Ligand | 1 | 2012 | 524 | 0.090 |
Why?
|
| Validation Studies as Topic | 1 | 2011 | 162 | 0.090 |
Why?
|
| T-Lymphocytes | 5 | 2021 | 10203 | 0.090 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 13385 | 0.090 |
Why?
|
| Neutralization Tests | 2 | 2009 | 725 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3412 | 0.080 |
Why?
|
| Viral Structural Proteins | 1 | 2009 | 94 | 0.080 |
Why?
|
| Mice, Transgenic | 4 | 2023 | 9520 | 0.080 |
Why?
|
| Protein Multimerization | 3 | 2020 | 974 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 874 | 0.080 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 4744 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 614 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2017 | 6504 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 22127 | 0.070 |
Why?
|
| Genes, MHC Class I | 1 | 2007 | 235 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 18220 | 0.070 |
Why?
|
| Protein Structure, Secondary | 2 | 2021 | 1216 | 0.070 |
Why?
|
| Models, Molecular | 4 | 2019 | 5406 | 0.060 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2005 | 91 | 0.060 |
Why?
|
| Antigens, Surface | 1 | 2010 | 1607 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 566 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2021 | 13402 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2014 | 2307 | 0.060 |
Why?
|
| Kidney | 1 | 2020 | 7033 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5321 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2020 | 8300 | 0.060 |
Why?
|
| HIV-1 | 1 | 2022 | 6851 | 0.060 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2006 | 379 | 0.060 |
Why?
|
| Liver | 1 | 2020 | 7514 | 0.060 |
Why?
|
| Demyelinating Diseases | 1 | 2006 | 352 | 0.060 |
Why?
|
| Optical Tweezers | 1 | 2024 | 85 | 0.060 |
Why?
|
| Neutrophils | 1 | 2016 | 3763 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 6199 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 1111 | 0.050 |
Why?
|
| Viral Vaccines | 1 | 2009 | 593 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2006 | 924 | 0.050 |
Why?
|
| Lymphocyte Activation | 3 | 2024 | 5478 | 0.050 |
Why?
|
| Vaccines, Subunit | 1 | 2023 | 157 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2009 | 6567 | 0.050 |
Why?
|
| Lymphocytes | 2 | 2011 | 2603 | 0.050 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2012 | 1640 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2006 | 774 | 0.050 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 254 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2007 | 1331 | 0.050 |
Why?
|
| Humans | 25 | 2024 | 761208 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 1737 | 0.050 |
Why?
|
| Molecular Mimicry | 1 | 2022 | 213 | 0.050 |
Why?
|
| Melanoma | 1 | 2019 | 5694 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2019 | 3933 | 0.050 |
Why?
|
| Influenza A virus | 1 | 2024 | 458 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2008 | 1803 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2020 | 110 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2864 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2015 | 18926 | 0.040 |
Why?
|
| Age of Onset | 1 | 2006 | 3307 | 0.040 |
Why?
|
| Nebraska | 1 | 2019 | 33 | 0.040 |
Why?
|
| Protein Stability | 1 | 2021 | 579 | 0.040 |
Why?
|
| Lung | 2 | 2017 | 9979 | 0.040 |
Why?
|
| HLA-A2 Antigen | 1 | 2019 | 209 | 0.040 |
Why?
|
| Virus Latency | 1 | 2022 | 354 | 0.040 |
Why?
|
| Peptide Library | 1 | 2019 | 347 | 0.040 |
Why?
|
| Pigmentation | 1 | 2019 | 143 | 0.040 |
Why?
|
| Asthma | 1 | 2017 | 6230 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 1 | 2020 | 872 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2015 | 11509 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2010 | 3044 | 0.040 |
Why?
|
| Cholesterol | 1 | 2006 | 2902 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2006 | 2475 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2022 | 4372 | 0.040 |
Why?
|
| Cytokines | 2 | 2017 | 7386 | 0.040 |
Why?
|
| Binding Sites | 1 | 2006 | 5988 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2019 | 5871 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2019 | 3603 | 0.030 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 9416 | 0.030 |
Why?
|
| Melanins | 1 | 2019 | 289 | 0.030 |
Why?
|
| Airway Remodeling | 1 | 2017 | 132 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2020 | 1978 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1624 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2017 | 476 | 0.030 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2016 | 242 | 0.030 |
Why?
|
| HIV Infections | 1 | 2022 | 17347 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2018 | 1162 | 0.030 |
Why?
|
| Mutation | 5 | 2019 | 30002 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2019 | 1487 | 0.030 |
Why?
|
| Male | 5 | 2020 | 360693 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2019 | 1251 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2020 | 3577 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2023 | 2426 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2016 | 660 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2016 | 696 | 0.030 |
Why?
|
| Alleles | 2 | 2019 | 6857 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 3057 | 0.030 |
Why?
|
| Models, Immunological | 1 | 2015 | 515 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 470 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 2189 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2013 | 355 | 0.030 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2016 | 432 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 342 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2017 | 1071 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2014 | 410 | 0.020 |
Why?
|
| Glioma | 1 | 2006 | 3452 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2012 | 274 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2011 | 5032 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2012 | 193 | 0.020 |
Why?
|
| Vaccination | 1 | 2023 | 3369 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2015 | 2740 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2021 | 23416 | 0.020 |
Why?
|
| Th17 Cells | 1 | 2017 | 794 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2013 | 598 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4243 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 16952 | 0.020 |
Why?
|
| Models, Biological | 1 | 2006 | 9457 | 0.020 |
Why?
|
| Genotype | 2 | 2019 | 12985 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2005 | 3753 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 17598 | 0.020 |
Why?
|
| Allergens | 1 | 2017 | 1433 | 0.020 |
Why?
|
| Chemokines | 1 | 2013 | 956 | 0.020 |
Why?
|
| Antigens, CD19 | 1 | 2012 | 424 | 0.020 |
Why?
|
| Fowlpox virus | 1 | 2009 | 21 | 0.020 |
Why?
|
| Actins | 1 | 2016 | 2046 | 0.020 |
Why?
|
| Defective Viruses | 1 | 2009 | 89 | 0.020 |
Why?
|
| Receptors, CCR | 1 | 2008 | 37 | 0.020 |
Why?
|
| Immunodominant Epitopes | 1 | 2010 | 237 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2012 | 965 | 0.020 |
Why?
|
| Inflammation | 2 | 2019 | 10759 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1728 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 1967 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 2171 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 5662 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2009 | 819 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 283 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2008 | 897 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 2009 | 366 | 0.020 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2006 | 46 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2009 | 612 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2017 | 2726 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2007 | 368 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2009 | 940 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2008 | 585 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 9025 | 0.020 |
Why?
|
| Female | 4 | 2018 | 392544 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 3770 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2013 | 2119 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 864 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2006 | 410 | 0.010 |
Why?
|
| Cell Line | 2 | 2009 | 15545 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2021 | 4822 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2011 | 2091 | 0.010 |
Why?
|
| Exons | 1 | 2009 | 2380 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2005 | 702 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 1553 | 0.010 |
Why?
|
| AIDS Vaccines | 1 | 2009 | 891 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2009 | 2328 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 1994 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3671 | 0.010 |
Why?
|
| Calcium | 1 | 2015 | 5719 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 2692 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2005 | 752 | 0.010 |
Why?
|
| Indoles | 1 | 2009 | 1830 | 0.010 |
Why?
|
| Antibodies | 1 | 2009 | 2415 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2005 | 1682 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 4107 | 0.010 |
Why?
|
| Phenotype | 1 | 2019 | 16575 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2010 | 2548 | 0.010 |
Why?
|
| Haplotypes | 1 | 2007 | 2715 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2006 | 1141 | 0.010 |
Why?
|
| Cell Death | 1 | 2006 | 1676 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6067 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2009 | 1977 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2009 | 3388 | 0.010 |
Why?
|
| Prognosis | 2 | 2010 | 29687 | 0.010 |
Why?
|
| Piperazines | 1 | 2009 | 2522 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3702 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 4537 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2009 | 2553 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 4612 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2006 | 3590 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2008 | 4009 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41496 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11067 | 0.010 |
Why?
|
| Aged | 2 | 2019 | 169288 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 221119 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 9477 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 15920 | 0.000 |
Why?
|
| Middle Aged | 2 | 2010 | 220853 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 17897 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 58952 | 0.000 |
Why?
|
| Time Factors | 1 | 2006 | 39957 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2010 | 64681 | 0.000 |
Why?
|